Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.

Benzer Materyaller

• Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.
  Yazar:: McLaughlin, J, ve diğerleri
  Baskı/Yayın Bilgisi: (1989)
• Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
  Yazar:: Kelliher, M A, ve diğerleri
  Baskı/Yayın Bilgisi: (1990)
• In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.
  Yazar:: McLaughlin, J, ve diğerleri
  Baskı/Yayın Bilgisi: (1987)
• BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
  Yazar:: Muller, A J, ve diğerleri
  Baskı/Yayın Bilgisi: (1991)
• The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.
  Yazar:: Lugo, T G, ve diğerleri
  Baskı/Yayın Bilgisi: (1989)